EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Suppression PCR-Based Selective Enrichment Sequencing for Pathogen and Antimicrobial Resistance Detection on Cell-Free DNA in Sepsis—A Targeted, Blood Culture-Independent Approach for Rapid Pathogen and Resistance Diagnostics in Septic Patients

Mirko Sonntag iD, Vanessa K Elgeti iD, Yevhen Vainshtein iD, Lucca Jenner, Jan Mueller iD, Thorsten Brenner, Sebastian O Decker iD, Kai Sohn

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25105463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Mirko Sonntag und 7 weiteren Autor:innen. Beteiligte Einrichtung: Innovation Field In-Vitro Diagnostics, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, 70569 Stuttgart, Germany. Hauptthemen laut MEDLINE: Sepsis, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis is a life-threatening syndrome triggered by infection and accompanied by high mortality, with antimicrobial resistances (AMRs) further escalating clinical challenges. The rapid and reliable detection of causative pathogens and AMRs are key factors for fast and appropriate treatment, in order to improve outcomes in septic patients. However, current sepsis diagnostics based on blood culture is limited by low sensitivity and specificity while current molecular approaches fail to enter clinical routine. Therefore, we developed a suppression PCR-based selective enrichment sequencing approach (SUPSETS), providing a molecular method combining multiplex suppression PCR with Nanopore sequencing to identify most common sepsis-causative pathogens and AMRs using plasma cell-free DNA. Applying only 1 mL of plasma, we targeted eight pathogens across three kingdoms and ten AMRs in a proof-of-concept study. SUPSETS was successfully tested in an experimental research study on the first ten clinical samples and revealed comparable results to clinical metagenomics while clearly outperforming blood culture. Several clinically relevant AMRs could be additionally detected. Furthermore, SUPSETS provided first pathogen and AMR-specific sequencing reads within minutes of starting sequencing, thereby potentially decreasing time-to-results to 11–13 h and suggesting diagnostic potential in sepsis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SepsisCell-Free Nucleic AcidsHumansDrug Resistance, BacterialBlood CultureDNA, BacterialMultiplex Polymerase Chain ReactionAnti-Bacterial AgentsBacteriaPolymerase Chain ReactionNanopore Sequencing

Stichwörter der Autor:innen

Nanopore sequencingantimicrobial resistancescell-free DNAnext-generation sequencingprecision diagnosticsreal-time diagnosticssepsissuppression PCR

Substanzen

Cell-Free Nucleic AcidsDNA, BacterialAnti-Bacterial Agents

Autor:innen und Institutionen

  • Innovation Field In-Vitro Diagnostics, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, 70569 Stuttgart, Germany.
  • Interfaculty Graduate School of Infection Biology and Microbiology (IGIM), Eberhard Karls University Tuebingen, 72076 Tuebingen, Germany.
  • Faculty of Medicine, Greifswald University Medicine, Fleischmannstr. 8, 17475 Greifswald, Germany.
  • Max Perutz Labs, Vienna Biocenter Campus (VBC), Vienna Biocenter 5, 1030 Vienna, Austria.
  • Max Perutz Labs, Department of Structural and Computational Biology, University of Vienna, CIBIV Vienna Biocenter 5, 1030 Vienna, Austria.
  • Vienna Biocenter PhD Program, a Doctoral School of the University of Vienna and the Medical University of Vienna, 1030 Vienna, Austria.

ORCID-Profile: Mirko Sonntag, Vanessa K Elgeti, Yevhen Vainshtein, Jan Mueller, Sebastian O Decker

Zitieren

APA

Sonntag, M., Elgeti, V. K., Vainshtein, Y., Jenner, L., Mueller, J., Brenner, T., Decker, S. O., & Sohn, K. (2024). Suppression PCR-Based Selective Enrichment Sequencing for Pathogen and Antimicrobial Resistance Detection on Cell-Free DNA in Sepsis—A Targeted, Blood Culture-Independent Approach for Rapid Pathogen and Resistance Diagnostics in Septic Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105463

Vancouver

Sonntag M, Elgeti VK, Vainshtein Y, Jenner L, Mueller J, Brenner T, et al. Suppression PCR-Based Selective Enrichment Sequencing for Pathogen and Antimicrobial Resistance Detection on Cell-Free DNA in Sepsis—A Targeted, Blood Culture-Independent Approach for Rapid Pathogen and Resistance Diagnostics in Septic Patients. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105463

BibTeX
@article{Sonntag2024,
  author = {Sonntag, Mirko and Elgeti, Vanessa K and Vainshtein, Yevhen and Jenner, Lucca and Mueller, Jan and Brenner, Thorsten and Decker, Sebastian O and Sohn, Kai},
  title = {Suppression PCR-Based Selective Enrichment Sequencing for Pathogen and Antimicrobial Resistance Detection on Cell-Free DNA in Sepsis—A Targeted, Blood Culture-Independent Approach for Rapid Pathogen and Resistance Diagnostics in Septic Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25105463}
}
Kostenlos starten →